A dual-label stable-isotopic protocol is suitable for determination of folate bioavailability in humans: Evaluation of urinary excretion and plasma folate kinetics of intravenous and oral doses of [13C5] and [2H2]folic acid

Journal of Nutrition

Volumn 127, Issue 12, 1997, Pages 2321-2327

  Rogers, Lisa M ^a   Pfeiffer, Christine M ^a   Bailey, Lynn B ^a   Gregory III, Jesse F ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

Bioavailability; Folate; Folic acid; Human; Stable isotopes

Indexed keywords

FOLIC ACID;

ADULT; ARTICLE; BIOAVAILABILITY; FEMALE; FOLATE METABOLISM; FOLIC ACID BLOOD LEVEL; HUMAN; INTESTINE ABSORPTION; MALE; NORMAL HUMAN; URINARY EXCRETION;

EID: 0031445355     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/127.12.2321     Document Type: Article

References (42)

1. Anderson, J. H., Kerr, D. J., Setanoians, A., Cooke, T. G. & McArdle, C. S. (1992) A pharmocokinetic comparison of intravenous versus intra-arterial folinic acid. Br. J. Cancer 65: 133-135.
2. Bailey, L. B., Barton, L. E., Hillier, S. E. & Cerda, J. J. (1988) Bioavailability of mono and polyglutamyl folate in human subjects. Nutr. Rep. Int. 38: 509-518.
3. Baumgartner, T. G., Schmidt, G. L., Thakker, K. M., Sitren, H. S., Cerda, J. J., Mahaffey, S. M. & Copeland, E. M. (1986) Bacterial endotoxin retention by inline intravenous filters. Am. J. Hosp. Pharm. 43: 681-684.
4. Bhandari, S. D. & Gregory, J. F. (1992) Folic acid, 5-methyl-tetrahydrofolate and 5-formyl-tetrahydrofolate exhibit equivalent intestinal absorption, metabolism and in vivo kinetics in rats. J. Nutr. 122: 1847-1854.
5. Boushey, C. J., Beresford, S.A.A., Omenn, G. S. & Motulsky, A. G. (1995) A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. J. Am. Med. Assoc. 274: 1049-1057.
6. Bunni, M. A., Rembiesa, B. M., Priest, D. G., Sahovic, E. & Stuart, R. (1989) Accumulation of tetrahydrofolates in human plasma after leucovorin administration. Cancer Chemother. Pharmacol. 23: 353-357.
7. Centers for Disease Control (1992) Recommendations for the use of folic acid to reduce the numbers of cases of spina bifida and other neural tube defects. Morbid. Mortal. Wkly. Rep. 41: 1-7.
8. Cuskelly, G. J., McNulty, H. & Scott, J. M. (1996) Effect of increasing dietary folate on red-cell folate: implications for prevention of neural tube defects. Lancet 347: 657-659.
9. 4]pteroylglutamic acid. J. Labelled Comp. Radiopharm. 36: 981-991.
10. Green, R. & Jacobsen, D. W. (1995) Clinical implications of hyperhomocysteinemia. In: Folate in Health and Disease (Bailey, L. B., ed.), pp. 195-235. M. Dekker, New York, NY.
11. Gregory, J. F. (1989) Chemical and nutritional aspects of folate research: analytical procedures, methods of folate synthesis, stability, and bioavailability of dietary folates. In: Advances in Food and Nutrition Research (Kinsella, J. E., ed.) vol. 33, pp. 1-101, Academic Press, San Diego, CA.
12. 2]folic acid: extent and specificity of deuterium labeling. J. Agric. Food Chem. 38: 1073-1076.
13. Gregory, J. F. (1995) The bioavailability of folate. In: Folate in Health and Disease (Bailey, L. B., ed.), pp. 195-235. M. Dekker, New York, NY.
14. Gregory, J. F. (1997) Bioavailability of folate. Eur. J. Clin. Nutr. 51: S54-S59.
15. Gregory, J. F., Bhandari, S. D., Bailey, L. B., Toth, J. P., Baumgartner, T. G. & Cerda, J. J. (1991) Relative bioavailability of deuterium-labeled monoglutamyl and hexaglutamyl folates in human subjects. Am. J. Clin. Nutr. 53: 736-740.
16. Gregory, J. F., Bhandari, S. D., Bailey, L. B., Toth, J. P., Baumgartner, T. G. & Cerda, J. J. (1992) Relative bioavailability of deuterium-labeled monoglutamyl tetrahydrofolates and folic acid in human subjects. Am. J. Clin. Nutr. 55: 1147-1153.
17. Gregory, J. F., Sartain, D. B. & Day, B.P.F. (1984) Fluorometric determination of folacin in biological materials using high performance liquid chromatography. J. Nutr. 114: 341-353.
18. Gregory, J. F. & Toth, J. P. (1988a) Preparation of folic acid specifically labelled with deuterium at the 3′,5′-positions. J. Labelled Comp. Radiopharm. 25: 1349-1359.
19. Gregory, J. F. & Toth, J. P. (1988b) Chemical synthesis of deuterium folate monoglutamate and in vivo assessment of urinary excretion of deuterated folates in man. Anal. Biochem. 170: 94-104.
20. 2 by acid catalyzed exchange with deuterium oxide. J. Labelled Compd. Radiopharm. 14: 479-486.
21. Kownacki-Brown, P. A., Wang, C., Bailey, L. B., Toth, J. P. & Gregory, J. F. (1993) Urinary excretion of deuterium-labeled folate and the metabolite p-aminobenzoylglutamate in humans. J. Nutr. 123: 1101-1108.
22. Loew, D., Eberhardt, A., Heseker, H. & Kübler, W. (1987) Zur plasmakinetik und elimination von folsäure. Klin. Wochenschr. 65: 520-524.
23. Mason, J. (1995) Folate status: effects on carcinogenesis. In: Folate in Health and Disease (Bailey, L. B., ed.), pp. 329-361. M. Dekker, New York, NY.
24. Menke, G., Müller, J., Weimann, H.-J. & Schuster, O. (1993) Bioverfügbarkeit von folsäure nach intramuskulärer und intravenöser gabe an gesunde versuchspersonen. Arzeneim.-Forsch. 43: 22-27.
25. Neter, J., Wasserman, W. & Kutner, M. H. (1985) Applied Linear Statistical Models: Regression, Analysis of Variance, and Experimental Designs, 2nd ed. R. D. Irwin, Homewood, IL.
26. Pastore, E. J. (1980) Folate and its reduced forms labeled with deuterium at carbon-7. Methods Enzymol. 66: 538-541.
27. Pfeiffer, C. M. & Gregory, J. F. (1997) Preparation of stable-isotopically labeled folates for in vivo investigation of folate absorption and metabolism. Methods Enzymol. 281: 106-116.
28. Pfeiffer, C. M., Rogers, L. M., Bailey, L. B. & Gregory, J. F. (1997) Absorption of folate from fortified cereal-grain products and of supplemental folate consumed with or without food determined using a dual-label stable-isotope protocol. Am. J. Clin. Nutr. (in press).
29. Plante, L. T., Williamson, K. L. & Pastore, E. J. (1980) Preparation of folic acid specifically labeled with carbon-13 in the benzoyl carbonyl. Methods Enzymol. 66: 533-535.
30. Poe, M. (1980) PMR characteristics of folic acid and analogs. Methods Enzymol. 66: 483-490.
31. Ritschel, W. A. (1992) Handbook of Basic Pharmacokinetics, 4th ed. Drug Intelligence Publications, Hamilton, IL.
32. Rowland, M. & Tozer, T. N. (1989) Clinical Pharmacokinetics: Concepts and Applications. Lea and Febiger, Philadelphia, PA.
33. Schuster, O., Weimann, H. J., Muller, J., Menke, A. & Menke, G. (1993) Pharmakokinetik und relative bioverfügbarkeit von eisen und folsäure bei gesunden versuchspersonen. Arzeneim.-Forsch. 43: 761-766.
34. Scott, J. M., Weir, D. G. & Kirke, P. N. (1995) Folate and neural tube defects. In: Folate in Health and Disease, (Bailey, L. B., ed.) pp. 329-360. Dekker, New York, NY.
35. Selhub, J., Ahmad, O. & Rosenberg, I. H. (1980) Preparation and use of affinity columns with bovine milk folate-binding protein covalently linked to Sepharose 4B. Methods Enzymol. 66: 686-690.
36. Steinberg, S. E. (1979) Kinetics of the normal folate enterohepatic cycle. J. Clin. Invest. 64: 83-88.
37. Steinberg, S. E. (1984) Mechanisms of folate homeostasis. Am. J. Physiol. 246: G319-G324.
38. Tamura, T. (1990) Microbiological assay of folates. In: Folic Acid Metabolism in Health and Disease (Picciano, M. F., Stokstad, E.L.R., Gregory J. F., eds.) pp. 121-37. John Wiley & Sons, New York, NY.
39. Toth, J. P. & Gregory, J. F. (1988) Analysis of folacin by GCMS: structure and mass spectra of fluorinated derivatives of para-aminobenzoyl glutamic acid. Biomed. Environ. Mass Spectrom. 17: 73-79.
40. Wei, M.-M., Bailey, L. B., Toth, J. P. & Gregory, J. F. (1996) Bioavailability for humans of deuterium-labeled monoglutamyl and polyglutamyl folates is affected by selected foods. J. Nutr. 126: 3100-3108.
41. Wolfrom, C., Hepp, R., Hartmann, R., Breithaupt, H. & Henze, G. (1990) Pharmacokinetic study of methotrexate, folinic acid and their serum metabolites in children treated with high-dose methotrexate and leucovorin rescue. Eur. J. Clin. Pharmacol. 39: 377-383.
42. Zittoun, J., Tonelli, A. P., De Gialluly, E., Hancock, C., Yacobi, A. & Johnson, J. B. (1993) Pharmacokinetic comparison of leucovorin and levoleucovorin. Eur. J. Clin. Pharmacol. 44: 569-573.